Cargando…

A149 CHARACTERIZING INAPPROPRIATE PROTON-PUMP INHIBITOR DISCONTINUATION IN PATIENTS WITH ESOPHAGEAL STRICTURES

BACKGROUND: Recent recommendations to reduce proton pump inhibitor (PPI) usage may cause uncertainty for clinicians and patients. We have shown increased PPI discontinuation rates in patients with esophageal strictures in recent years. Purpose: We aim to determine the appropriateness of PPI disconti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kecskemeti, K L, Borgaonkar, M, McGrath, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991149/ http://dx.doi.org/10.1093/jcag/gwac036.149

Ejemplares similares

Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007)

Predictors of Inappropriate Proton Pump Inhibitors Use in Elderly Patients
por: Voukelatou, Panagiota, et al.
Publicado: (2019)

A170 SERUM ALBUMIN AS A MEASURE OF INFLAMMATION OR MALNUTRITION IN INFLAMMATORY BOWEL DISEASE: A CROSS SECTIONAL STUDY
por: Squirell, E, et al.
Publicado: (2022)

A197 INVESTIGATING THE PROTON-PUMP INHIBITOR USE PRECEDING AND POST AN INFLAMMATORY BOWEL DISEASE DIAGNOSIS
por: Singh, N, et al.
Publicado: (2023)

A146 BENIGN GASTRIC ULCER COMPLICATED BY GASTROJEJUNAL FISTULA FORMATION HEALED WITH PROTON-PUMP INHIBITOR
por: Winter, R, et al.
Publicado: (2023)

A66 PROTON PUMP INHIBITORS AND THE RISK OF INFLAMMATORY BOWEL DISEASE: A REAL WORLD POPULATION-BASED COHORT STUDY
por: Yanofsky, R P, et al.
Publicado: (2023)

Eosinophilic Esophagitis on and off Proton Pump Inhibitor
por: Zimmer, Vincent, et al.
Publicado: (2023)

Community-dwelling older adults’ awareness of the inappropriate use of proton pump inhibitors
por: Rababa, Mohammad, et al.
Publicado: (2020)

Reducing the Inappropriate Use of Proton Pump Inhibitors in an Internal Medicine Residency Clinic
por: Boster, Joshua, et al.
Publicado: (2020)

Predictors for inappropriate proton pump inhibitor use: observational study in primary care
por: Koggel, Lieke Maria, et al.
Publicado: (2022)

A143 PEDIATRIC EOSINOPHILIC ESOPHAGITIS IN CANADA: A MULTI-CENTER COHORT WITH FOCUS ON THE STRICTURING PHENOTYPE
por: Burnett, D, et al.
Publicado: (2023)

P02.149. Integrative integrated migraine care: preliminary evaluation
por: Lauche, R, et al.
Publicado: (2012)

Effect of proton pump inhibitors on gastric volume, gastric pH and gastric intramucosal pH in critically ill patients in the ICU
por: Gursoy, O, et al.
Publicado: (2006)

Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
por: Sloan, Joshua, et al.
Publicado: (2016)

P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma
por: Malard, Florent, et al.
Publicado: (2021)

Effects of proton pump inhibitor versus H2-receptor antagonist stress ulcer prophylaxis on ventilator-associated pneumonia: a pilot study
por: Fogas, JF, et al.
Publicado: (2013)

P029: Regional differences in Clostridium difficile infections (CDI) in relation to fluoroquinolone (FQ) and proton pump inhibitor (PPI) use, Finland, 2008-2011
por: Kanerva, M, et al.
Publicado: (2013)

A Randomized Open-Label Study of Two Methods of Proton Pump Inhibitors Discontinuation
por: Hendricks, Emily, et al.
Publicado: (2021)

Inappropriate Use of Proton Pump Inhibitors Increases Cardiovascular Events in Patients with Coronary Heart Disease
por: Hu, Wen, et al.
Publicado: (2022)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
por: Gutiérrez-Junquera, Carolina, et al.
Publicado: (2018)

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019)

Effects of proton pump inhibitor use on the esophageal microbial community
por: Tasnim, Sadia, et al.
Publicado: (2020)

Experience with the Molecular Adsorbents Recirculating System: Chinese results on 149 patients with liver failure based on hepatitis B
por: Wang, M, et al.
Publicado: (2004)

Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours
por: Korse, C M, et al.
Publicado: (2011)

Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
por: Holmberg, Dag, et al.
Publicado: (2022)

Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors
por: Lai, Pauline Siew Mei, et al.
Publicado: (2014)

Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study
por: Haroon, Muhammad, et al.
Publicado: (2013)

The inappropriate use of proton pump inhibitors and its associated factors among community-dwelling older adults
por: Rababa, Mohammad, et al.
Publicado: (2021)

Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit
por: Ladjouzi, Nadia, et al.
Publicado: (2022)

P149: Production and use of an alcohol-based handrub for hand hygiene in the point G University Hospital of Bamako Mali
por: Bengaly, L, et al.
Publicado: (2013)

The prevalence of HIV-1 DNA in AIDS-related lymphoma and Kaposi Sarcoma throughout the AIDS epidemic
por: Huysentruyt, Leanne C, et al.
Publicado: (2012)

Impact of ketogenesis and strong ion difference on acid-base in our CICU
por: Clark, T, et al.
Publicado: (2012)

P149 The role of OSA pathophysiological traits on mandibular advancement treatment response and efficacy of a novel mandibular advancement device
por: Tong, B, et al.
Publicado: (2021)

Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy
por: DiGiovanni, Ernest L., et al.
Publicado: (2016)

Introduction of an external noninvasive cooling device for effective implementation of Intensive Care Society standards post cardiac arrest
por: McGrath, J, et al.
Publicado: (2009)

Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
por: Yasugi, Kengo, et al.
Publicado: (2021)

A129 CYP2C19 PHARMACOGENETIC TESTING IN PAEDIATRIC PATIENTS WITH EOSINOPHILIC ESOPHAGITIS INFLUENCES DOSING OF PROTON-PUMP-INHIBITORS AND RESPONSE TO THERAPY
por: Bortolin, K A, et al.
Publicado: (2022)

Proton-pump Inhibitor Response Prediction Using Esophageal microRNAs in Children With Eosinophilic Esophagitis
por: Cañas, José Antonio, et al.
Publicado: (2020)

Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study
por: Wang, Mengmeng, et al.
Publicado: (2022)

A review of a trauma database for inappropriateness of transfused blood products
por: Mahambrey, T, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_f1rngkchmd7a85doa8knpmmjk1